[1] CELLI B, FABBRI L, CRINER G, et al. Definition and nomenclature of chronic obstructive pulmonary disease:time for its revision[J]. Am J Respir Crit Care Med, 2022, 206(11): 1317-1325. [2] 任嘉玮, 张益辉, 董芳,等.稳定期COPD患者深吸气量与运动耐力的关系[J].国际呼吸杂志,2017, 37(19):1464-1467. [3] ELBEHAIRY A F, O'DONNELL C D, ABD ELHAMEED A, et al. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease[J]. J Appl Physiol(1985), 2019, 127(4):1107-1116. [4] TANABE N, RHEE C K, SATO S, et al. Disproportionally impaired diffusion capacity relative to airflow limitation in COPD[J]. COPD, 2020, 17(6):627-634. [5] 周敏. 2020版慢性阻塞性肺疾病全球倡议解读[J]. 中华结核和呼吸杂志, 2020, 43(3): 268-271. [6] 中华医学会呼吸病学分会肺功能专业组.肺功能检查指南-肺弥散功能检查[J]. 中华结核和呼吸杂志, 2015, 38(3):164-169. [7] HARVEY B G, STRULOVICI-BAREL Y,KANER R J, et al. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity[J].Eur Respir J, 2015, 46(6):1589-1597. [8] VOGEL-CLAUSSEN J, SCHÖNFELD C O,KAIREIT T F, et al. Effect of indacaterol/glycopyrronium on pulmonary perfusion and ventilation in hyperinflated patients with chronic obstructive pulmonary disease(CLAIM). A double-blind, randomized, crossover trial[J]. Am J Respir Crit Care Med, 2019, 199(9):1086-1096. [9] DE-TORRES J P, O'DONNELL D E, MARÍN J M, et al. Clinical and prognostic impact of low diffusing capacity for carbon monoxide values in patients with global initiative for obstructive lung disease I COPD[J]. Chest, 2021, 160(3):872-878. [10] WOUTERS E F M, FRANSSEN F M. Chronic obstructive pulmonary disease: shifting the paradigm to the vasculature[J]. Am J Respir Crit Care Med, 2019, 199(3):258-259. [11] JAMES M D, PHILLIPS D B, EIBEHAIRY A F, et al. Mechanisms of exertional dyspnea in patients with mild COPD and a low restin DLCO[J]. COPD, 2021, 18(5): 501-510. [12] FAISAL A, ALGHAMDI B J, CIAVAGLIA C E, et al. Common mechanisms of dyspnea in chronicinterstitial and obstructive lung disorders[J]. Am J Respir Crit Care Med, 2016, 193(3):299-309. [13] GE Y M, NIE S, JIA N, et al. Analysis of influencing factors for exercise ventilation efficiency of COPD patients[J]. Evid Based Complement Alternat Med, 2022, 2022:8376085. [14] ELBEHAIRY A F, CIAVAGLIA C E, WEBB K A, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise Intolerance[J]. Am J Respir Crit Care Med, 2015, 191(12):1384-1394. [15] ELBEHAIRY A F, WEBB K A, LAVENEZIANA P, et al. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD[J]. Respir Physiol Neurobiol, 2018, 252(6): 64-71. |